ValiRx (VAL) News Today GBX 0.71 0.00 (-0.28%) (As of 04:36 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ValiRx Successfully Raises £1.57 Million in Fundraising InitiativeDecember 10, 2024 | tipranks.comValiRx Plc Launches Conditional Fundraising DriveDecember 9, 2024 | tipranks.comValiRx Secures Funding for Prostate Cancer ResearchNovember 22, 2024 | markets.businessinsider.comValiRX adds to streak of deals with cancer cell test materials winNovember 19, 2024 | lse.co.ukAIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 millionNovember 19, 2024 | lse.co.ukValiRx Marks Milestone with New Product LaunchNovember 18, 2024 | msn.comPhilip Morris raises annual guidance as higher cigarette prices fuel earnings beatOctober 23, 2024 | msn.comEARNINGS: Kendrick Resources loss narrows; Emmerson CFO to departSeptember 27, 2024 | lse.co.ukValiRx plc (VAL.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comNo savings after inflation? I’d use the Warren Buffett method to build wealthSeptember 18, 2024 | msn.comValiRx Share Chat (VAL)September 17, 2024 | lse.co.ukTRADING UPDATES: Light Science Technologies wins two new contractsSeptember 10, 2024 | lse.co.ukCornish Metals Inc.: Cornish Metals Appoints Don Turvey as Chief Executive OfficerAugust 13, 2024 | finanznachrichten.dePublication of Final TermsAugust 1, 2024 | lse.co.ukValiRx PLC VALMay 26, 2024 | morningstar.comLONDON MARKET CLOSE: London gets boost thanks to rate cut hopesMay 20, 2024 | lse.co.ukValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grantMay 20, 2024 | lse.co.ukEARNINGS AND TRADING: Tullow Oil on track to hit free cash flow targetMay 16, 2024 | lse.co.ukTRADING UPDATES: Vertu Motors ups dividend as hails record revenueMay 15, 2024 | lse.co.ukNew method discovered to halt active cancer cellsFebruary 28, 2024 | msn.comScientists discover 'two-punch' method to eliminate cancer cellsFebruary 27, 2024 | uk.news.yahoo.comValiRx says requisition notice from shareholder group is invalidFebruary 13, 2024 | lse.co.ukTRADING UPDATES: ValiRx receives shareholder request for board changeFebruary 9, 2024 | lse.co.ukEuropean Stocks Close Mostly HigherDecember 5, 2023 | markets.businessinsider.comEuropean Markets Move Mostly HigherDecember 5, 2023 | markets.businessinsider.comValiRx says ValiSeek inks deal to licence VAL401 drug with AmbroseDecember 5, 2023 | lse.co.ukValiRx PLC EAJFNovember 15, 2023 | morningstar.comValiRx signs deal to evaluate StingRay Bio drug candidatesNovember 10, 2023 | lse.co.ukCORRECT (Oct 5): ICG Enterprise ups interim payout on better resultsOctober 6, 2023 | lse.co.ukValiRx sees no reason for shares jump; notes TheoremRx mulls mergerOctober 6, 2023 | lse.co.ukVAL.L - ValiRx plcSeptember 11, 2023 | finance.yahoo.comValiRx interim loss widens as costs increase; hails Inaphaea progressAugust 24, 2023 | lse.co.ukValiRx Shares Rise on Higher Income Expectations From Inaphaea BioLabsAugust 24, 2023 | marketwatch.comValiRx signs collaborative services agreement with AgilityAugust 14, 2023 | lse.co.ukValiRx Shares Rise After Collaborative Services Agreement With AgilityAugust 14, 2023 | marketwatch.comValiRx Shares Rise After Subsidiary Secures ContractJuly 19, 2023 | marketwatch.comTRADING UPDATES: All Things Considered raises funds to buy SandbagJune 28, 2023 | lse.co.ukValiRx shares drop after cancer drug research droppedJune 16, 2023 | lse.co.ukValiRx Shares Fall After Cancer-Drug Development AbandonedJune 16, 2023 | marketwatch.comValiRx Changes IP Exclusivity Terms With TheoremRx to Exclude Greater ChinaJune 8, 2023 | marketwatch.comValiRx expands cancer research agreement with University of BarcelonaJune 7, 2023 | lse.co.ukSelf Storage Gr Share ChatJune 3, 2023 | lse.co.ukMilner Therapeutics Institute welcomes Cathy Tralau-Stewart as executive directorMay 4, 2023 | msn.comGlobal Endometriosis Drugs Market Research Growth, Regions, Type and Application, Forecast Analysis to 2023-2030 By VMReportsMarch 26, 2023 | marketwatch.comSuzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' CytolytixNovember 10, 2022 | lse.co.ukValiRx teams with King's College London for cancer projectOctober 25, 2022 | lse.co.ukValiRx Shares Rise on Subsidiary's Intellectual Property License AgreementOctober 25, 2022 | marketwatch.comGlobal Endometriosis Drugs Market to Reach $2.9 Billion by 2027 - Yahoo FinanceOctober 18, 2022 | finance.yahoo.comValiRx Plc - Ada Lovelace Day 2022, in conversation with ValiRx's CEO - Marketscreener.comOctober 12, 2022 | marketscreener.comUK announces 40 billion-pound liquidity plan for power firms | Financial News - London South EastSeptember 8, 2022 | lse.co.uk Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << VAL Media Mentions By Week VAL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VAL News Sentiment▼0.000.56▲Average Medical News Sentiment VAL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VAL Articles This Week▼00▲VAL Articles Average Week Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EQTEC News Webis News Shell News BP News Woodside Energy Group News Melrose Industries News Bridgepoint Group News TotalEnergies News Kosmos Energy News Diversified Energy News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:VAL) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.